カテゴリー： Market Monitor Global, 世界, 部品/材料

免疫グロブリン皮下注射の世界市場見通し2023年-2029年

◆英語タイトル：Immune Globulin Subcutaneous Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY2838 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：70 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Immune Globulin Subcutaneous Market 調査レポートは次の情報を含め、グローバルにおけるの免疫グロブリン皮下注射市場規模と予測を収録しています。・世界の免疫グロブリン皮下注射市場：売上、2018年-2023年、2024年-2029年
・世界の免疫グロブリン皮下注射市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の免疫グロブリン皮下注射市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「2g」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

免疫グロブリン皮下注射のグローバル主要企業は、Takeda、 CSLなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、免疫グロブリン皮下注射のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の免疫グロブリン皮下注射市場：タイプ別、2018年-2023年、2024年-2029年
世界の免疫グロブリン皮下注射市場：タイプ別市場シェア、2022年
・2g、4g、10g、その他

世界の免疫グロブリン皮下注射市場：用途別、2018年-2023年、2024年-2029年
世界の免疫グロブリン皮下注射市場：用途別市場シェア、2022年
・免疫不全、自己免疫疾患、急性感染症

世界の免疫グロブリン皮下注射市場：地域・国別、2018年-2023年、2024年-2029年
世界の免疫グロブリン皮下注射市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における免疫グロブリン皮下注射のグローバル売上、2018年-2023年
・主要企業における免疫グロブリン皮下注射のグローバル売上シェア、2022年
・主要企業における免疫グロブリン皮下注射のグローバル販売量、2018年-2023年
・主要企業における免疫グロブリン皮下注射のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Takeda、 CSL

*************************************************************

・調査・分析レポートの概要
免疫グロブリン皮下注射市場の定義
市場セグメント
世界の免疫グロブリン皮下注射市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の免疫グロブリン皮下注射市場規模
世界の免疫グロブリン皮下注射市場規模：2022年 VS 2029年
世界の免疫グロブリン皮下注射市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの免疫グロブリン皮下注射の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の免疫グロブリン皮下注射製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：2g、4g、10g、その他
免疫グロブリン皮下注射のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫不全、自己免疫疾患、急性感染症
免疫グロブリン皮下注射の用途別グローバル売上・予測

・地域別市場分析
地域別免疫グロブリン皮下注射市場規模 2022年と2029年
地域別免疫グロブリン皮下注射売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Takeda、 CSL
...

Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency
This report aims to provide a comprehensive presentation of the global market for Immune Globulin Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Subcutaneous. This report contains market size and forecasts of Immune Globulin Subcutaneous in global, including the following market information:
Global Immune Globulin Subcutaneous Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Immune Globulin Subcutaneous Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Immune Globulin Subcutaneous companies in 2022 (%)
The global Immune Globulin Subcutaneous market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
2g Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immune Globulin Subcutaneous include Takeda and CSL etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Globulin Subcutaneous manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Globulin Subcutaneous Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Immune Globulin Subcutaneous Market Segment Percentages, by Type, 2022 (%)
2g
4g
10g
Other
Global Immune Globulin Subcutaneous Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Immune Globulin Subcutaneous Market Segment Percentages, by Application, 2022 (%)
Immunodeficiency
Autoimmune Disease
Acute Infection
Global Immune Globulin Subcutaneous Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Immune Globulin Subcutaneous Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immune Globulin Subcutaneous revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Immune Globulin Subcutaneous revenues share in global market, 2022 (%)
Key companies Immune Globulin Subcutaneous sales in global market, 2018-2023 (Estimated), (MT)
Key companies Immune Globulin Subcutaneous sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immune Globulin Subcutaneous, market overview.
Chapter 2: Global Immune Globulin Subcutaneous market size in revenue and volume.
Chapter 3: Detailed analysis of Immune Globulin Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immune Globulin Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Immune Globulin Subcutaneous capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Immune Globulin Subcutaneous Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Globulin Subcutaneous Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Globulin Subcutaneous Overall Market Size
2.1 Global Immune Globulin Subcutaneous Market Size: 2022 VS 2029
2.2 Global Immune Globulin Subcutaneous Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Immune Globulin Subcutaneous Sales: 2018-2029
3 Company Landscape
3.1 Top Immune Globulin Subcutaneous Players in Global Market
3.2 Top Global Immune Globulin Subcutaneous Companies Ranked by Revenue
3.3 Global Immune Globulin Subcutaneous Revenue by Companies
3.4 Global Immune Globulin Subcutaneous Sales by Companies
3.5 Global Immune Globulin Subcutaneous Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Immune Globulin Subcutaneous Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immune Globulin Subcutaneous Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Globulin Subcutaneous Players in Global Market
3.8.1 List of Global Tier 1 Immune Globulin Subcutaneous Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Globulin Subcutaneous Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Immune Globulin Subcutaneous Market Size Markets, 2022 & 2029
4.1.2 2g
4.1.3 4g
4.1.4 10g
4.1.5 Other
4.2 By Type – Global Immune Globulin Subcutaneous Revenue & Forecasts
4.2.1 By Type – Global Immune Globulin Subcutaneous Revenue, 2018-2023
4.2.2 By Type – Global Immune Globulin Subcutaneous Revenue, 2024-2029
4.2.3 By Type – Global Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
4.3 By Type – Global Immune Globulin Subcutaneous Sales & Forecasts
4.3.1 By Type – Global Immune Globulin Subcutaneous Sales, 2018-2023
4.3.2 By Type – Global Immune Globulin Subcutaneous Sales, 2024-2029
4.3.3 By Type – Global Immune Globulin Subcutaneous Sales Market Share, 2018-2029
4.4 By Type – Global Immune Globulin Subcutaneous Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Immune Globulin Subcutaneous Market Size, 2022 & 2029
5.1.2 Immunodeficiency
5.1.3 Autoimmune Disease
5.1.4 Acute Infection
5.2 By Application – Global Immune Globulin Subcutaneous Revenue & Forecasts
5.2.1 By Application – Global Immune Globulin Subcutaneous Revenue, 2018-2023
5.2.2 By Application – Global Immune Globulin Subcutaneous Revenue, 2024-2029
5.2.3 By Application – Global Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
5.3 By Application – Global Immune Globulin Subcutaneous Sales & Forecasts
5.3.1 By Application – Global Immune Globulin Subcutaneous Sales, 2018-2023
5.3.2 By Application – Global Immune Globulin Subcutaneous Sales, 2024-2029
5.3.3 By Application – Global Immune Globulin Subcutaneous Sales Market Share, 2018-2029
5.4 By Application – Global Immune Globulin Subcutaneous Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Immune Globulin Subcutaneous Market Size, 2022 & 2029
6.2 By Region – Global Immune Globulin Subcutaneous Revenue & Forecasts
6.2.1 By Region – Global Immune Globulin Subcutaneous Revenue, 2018-2023
6.2.2 By Region – Global Immune Globulin Subcutaneous Revenue, 2024-2029
6.2.3 By Region – Global Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
6.3 By Region – Global Immune Globulin Subcutaneous Sales & Forecasts
6.3.1 By Region – Global Immune Globulin Subcutaneous Sales, 2018-2023
6.3.2 By Region – Global Immune Globulin Subcutaneous Sales, 2024-2029
6.3.3 By Region – Global Immune Globulin Subcutaneous Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Immune Globulin Subcutaneous Revenue, 2018-2029
6.4.2 By Country – North America Immune Globulin Subcutaneous Sales, 2018-2029
6.4.3 US Immune Globulin Subcutaneous Market Size, 2018-2029
6.4.4 Canada Immune Globulin Subcutaneous Market Size, 2018-2029
6.4.5 Mexico Immune Globulin Subcutaneous Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Immune Globulin Subcutaneous Revenue, 2018-2029
6.5.2 By Country – Europe Immune Globulin Subcutaneous Sales, 2018-2029
6.5.3 Germany Immune Globulin Subcutaneous Market Size, 2018-2029
6.5.4 France Immune Globulin Subcutaneous Market Size, 2018-2029
6.5.5 U.K. Immune Globulin Subcutaneous Market Size, 2018-2029
6.5.6 Italy Immune Globulin Subcutaneous Market Size, 2018-2029
6.5.7 Russia Immune Globulin Subcutaneous Market Size, 2018-2029
6.5.8 Nordic Countries Immune Globulin Subcutaneous Market Size, 2018-2029
6.5.9 Benelux Immune Globulin Subcutaneous Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Immune Globulin Subcutaneous Revenue, 2018-2029
6.6.2 By Region – Asia Immune Globulin Subcutaneous Sales, 2018-2029
6.6.3 China Immune Globulin Subcutaneous Market Size, 2018-2029
6.6.4 Japan Immune Globulin Subcutaneous Market Size, 2018-2029
6.6.5 South Korea Immune Globulin Subcutaneous Market Size, 2018-2029
6.6.6 Southeast Asia Immune Globulin Subcutaneous Market Size, 2018-2029
6.6.7 India Immune Globulin Subcutaneous Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Immune Globulin Subcutaneous Revenue, 2018-2029
6.7.2 By Country – South America Immune Globulin Subcutaneous Sales, 2018-2029
6.7.3 Brazil Immune Globulin Subcutaneous Market Size, 2018-2029
6.7.4 Argentina Immune Globulin Subcutaneous Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Immune Globulin Subcutaneous Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Immune Globulin Subcutaneous Sales, 2018-2029
6.8.3 Turkey Immune Globulin Subcutaneous Market Size, 2018-2029
6.8.4 Israel Immune Globulin Subcutaneous Market Size, 2018-2029
6.8.5 Saudi Arabia Immune Globulin Subcutaneous Market Size, 2018-2029
6.8.6 UAE Immune Globulin Subcutaneous Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Immune Globulin Subcutaneous Major Product Offerings
7.1.4 Takeda Immune Globulin Subcutaneous Sales and Revenue in Global (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Immune Globulin Subcutaneous Major Product Offerings
7.2.4 CSL Immune Globulin Subcutaneous Sales and Revenue in Global (2018-2023)
7.2.5 CSL Key News & Latest Developments
8 Global Immune Globulin Subcutaneous Production Capacity, Analysis
8.1 Global Immune Globulin Subcutaneous Production Capacity, 2018-2029
8.2 Immune Globulin Subcutaneous Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Globulin Subcutaneous Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immune Globulin Subcutaneous Supply Chain Analysis
10.1 Immune Globulin Subcutaneous Industry Value Chain
10.2 Immune Globulin Subcutaneous Upstream Market
10.3 Immune Globulin Subcutaneous Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Globulin Subcutaneous Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Immune Globulin Subcutaneous in Global Market
Table 2. Top Immune Globulin Subcutaneous Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Immune Globulin Subcutaneous Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Immune Globulin Subcutaneous Revenue Share by Companies, 2018-2023
Table 5. Global Immune Globulin Subcutaneous Sales by Companies, (MT), 2018-2023
Table 6. Global Immune Globulin Subcutaneous Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Immune Globulin Subcutaneous Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Immune Globulin Subcutaneous Product Type
Table 9. List of Global Tier 1 Immune Globulin Subcutaneous Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Globulin Subcutaneous Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Immune Globulin Subcutaneous Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Immune Globulin Subcutaneous Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Immune Globulin Subcutaneous Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Immune Globulin Subcutaneous Sales (MT), 2018-2023
Table 15. By Type - Global Immune Globulin Subcutaneous Sales (MT), 2024-2029
Table 16. By Application – Global Immune Globulin Subcutaneous Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Immune Globulin Subcutaneous Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Immune Globulin Subcutaneous Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Immune Globulin Subcutaneous Sales (MT), 2018-2023
Table 20. By Application - Global Immune Globulin Subcutaneous Sales (MT), 2024-2029
Table 21. By Region – Global Immune Globulin Subcutaneous Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Immune Globulin Subcutaneous Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Immune Globulin Subcutaneous Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Immune Globulin Subcutaneous Sales (MT), 2018-2023
Table 25. By Region - Global Immune Globulin Subcutaneous Sales (MT), 2024-2029
Table 26. By Country - North America Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Immune Globulin Subcutaneous Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Immune Globulin Subcutaneous Sales, (MT), 2018-2023
Table 29. By Country - North America Immune Globulin Subcutaneous Sales, (MT), 2024-2029
Table 30. By Country - Europe Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Immune Globulin Subcutaneous Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Immune Globulin Subcutaneous Sales, (MT), 2018-2023
Table 33. By Country - Europe Immune Globulin Subcutaneous Sales, (MT), 2024-2029
Table 34. By Region - Asia Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Immune Globulin Subcutaneous Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Immune Globulin Subcutaneous Sales, (MT), 2018-2023
Table 37. By Region - Asia Immune Globulin Subcutaneous Sales, (MT), 2024-2029
Table 38. By Country - South America Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Immune Globulin Subcutaneous Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Immune Globulin Subcutaneous Sales, (MT), 2018-2023
Table 41. By Country - South America Immune Globulin Subcutaneous Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Immune Globulin Subcutaneous Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Immune Globulin Subcutaneous Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Immune Globulin Subcutaneous Sales, (MT), 2024-2029
Table 46. Takeda Company Summary
Table 47. Takeda Immune Globulin Subcutaneous Product Offerings
Table 48. Takeda Immune Globulin Subcutaneous Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Takeda Key News & Latest Developments
Table 50. CSL Company Summary
Table 51. CSL Immune Globulin Subcutaneous Product Offerings
Table 52. CSL Immune Globulin Subcutaneous Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 53. CSL Key News & Latest Developments
Table 54. Immune Globulin Subcutaneous Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 55. Global Immune Globulin Subcutaneous Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Immune Globulin Subcutaneous Production by Region, 2018-2023 (MT)
Table 57. Global Immune Globulin Subcutaneous Production by Region, 2024-2029 (MT)
Table 58. Immune Globulin Subcutaneous Market Opportunities & Trends in Global Market
Table 59. Immune Globulin Subcutaneous Market Drivers in Global Market
Table 60. Immune Globulin Subcutaneous Market Restraints in Global Market
Table 61. Immune Globulin Subcutaneous Raw Materials
Table 62. Immune Globulin Subcutaneous Raw Materials Suppliers in Global Market
Table 63. Typical Immune Globulin Subcutaneous Downstream
Table 64. Immune Globulin Subcutaneous Downstream Clients in Global Market
Table 65. Immune Globulin Subcutaneous Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Immune Globulin Subcutaneous Segment by Type in 2022
Figure 2. Immune Globulin Subcutaneous Segment by Application in 2022
Figure 3. Global Immune Globulin Subcutaneous Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immune Globulin Subcutaneous Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immune Globulin Subcutaneous Revenue, 2018-2029 (US$, Mn)
Figure 7. Immune Globulin Subcutaneous Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Immune Globulin Subcutaneous Revenue in 2022
Figure 9. By Type - Global Immune Globulin Subcutaneous Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 11. By Type - Global Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 12. By Type - Global Immune Globulin Subcutaneous Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Immune Globulin Subcutaneous Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 15. By Application - Global Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 16. By Application - Global Immune Globulin Subcutaneous Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Immune Globulin Subcutaneous Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Immune Globulin Subcutaneous Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 20. By Region - Global Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 21. By Country - North America Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 22. By Country - North America Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 23. US Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 28. Germany Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 29. France Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 37. China Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 41. India Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 43. By Country - South America Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 44. Brazil Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Immune Globulin Subcutaneous Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Immune Globulin Subcutaneous Sales Market Share, 2018-2029
Figure 48. Turkey Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Immune Globulin Subcutaneous Revenue, (US$, Mn), 2018-2029
Figure 52. Global Immune Globulin Subcutaneous Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Immune Globulin Subcutaneous by Region, 2022 VS 2029
Figure 54. Immune Globulin Subcutaneous Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫グロブリン皮下注射の世界市場見通し2023年-2029年(Immune Globulin Subcutaneous Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

免疫グロブリン皮下注射の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp